Related Articles
Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update
Read the full article here
Considering How TAILORx Transformed Node-Negative Breast Cancer Treatment
During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone receptor–positive/HER2-negative breast cancer.
Aktiia gets FDA clearance for OTC cuffless blood pressure monitor
The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.
‘AI receptionist’ cuts time and costs for Zara Medical
Seventy percent of calls require no human intervention. Data is free of human error. Providers save more than two hours per day. Staff no longer…
High-frequency data reveal limits of adaptation to heat in animal agriculture
Milk yield decreases nonlinearly with heat, with effects lasting over 10 days and only partial mitigation from adaptation.
Editorial Commentary | Urology Practice
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
REMS for currently approved BCMA- and CD19-directed autologous CAR T-cell immunotherapies eliminated – The Cancer Letter
FDA has determined that a Risk Evaluation and Mitigation Strategy (REMS) is no longer necessary to ensure that the benefits of these CAR T-cell immunotherapies…
